CLINICO-IMMUNOLOGICAL EVALUATION OF THE EFFECTIVENESS OF INTRAVENOUS IMMUNOGLOBULINS AS AN ADJUVANT THERAPY FOR SURGICAL SEPSIS

Cover Page


Cite item

Full Text

Abstract

We observed 46 patients with sepsis, which were divided into 2 groups. I group (25 patients) received traditional treatment, II group (21 patients) in addition to conventional therapy received enriched IVIG (IgM+IgA). Comparative assessment of the combination of intravenous immunoglobulin’s and traditional therapy indicated the clinical effectiveness of IVIG therapy, which results in reducing the severity of systemic inflammation, the severity of the disease and the mortality in patients with surgical sepsis.

About the authors

V. B. Shumatov

State budget educational institute of higher professional education Pacific State MedicalUniversity of Ministry of health Russian Federation

Email: fake@neicon.ru

Doctor of Sciences, Professor of the Department of intensive care, anesthesiology, intensive care and emergency medical services,

Vladivostok

Russian Federation

V. A. Lazanovich

State budget educational institute of higher professional education Pacific State MedicalUniversity of Ministry of health Russian Federation

Author for correspondence.
Email: immuno2003@mail.ru

Ph.D., assistant professor, Department of normal and Pathological Physiology,

 

Russian Federation

V. E. Krasnikov

State budget educational institute of higher professional education Pacific State MedicalUniversity of Ministry of health Russian Federation

Email: fake@neicon.ru

Ph.D., assistant professor, Department of normal and Pathological Physiology,

Vladivostok

Russian Federation

References

  1. Busani S., Damiani E., Cavazzuti I. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol. 2016. Vol. 82. P. 559–572.
  2. Шуматов В. Б., Лазанович В. А., Павлов В. А., Ермакова Н. Д., Просекова Е. В. Внутривенные иммуноглобулины в адъювантной терапии сепсиса. Тихоокеанский медицинский журнал, 2017. № 242 С. 42–45.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Shumatov V.B., Lazanovich V.A., Krasnikov V.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies